{
    "organizations": [],
    "uuid": "fe1e046af115edde5723ebbf0e84df7762cabff1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pacira-says-fda-committee-did-not/brief-pacira-says-fda-committee-did-not-reach-a-unanimous-decision-for-exparel-as-a-nerve-block-to-produce-regional-analgesia-idUSFWN1Q51GX",
    "ord_in_thread": 0,
    "title": "BRIEF-Pacira Says FDA ‍committee ‍Did Not Reach A Unanimous Decision For Exparel As A Nerve Block To Produce Regional Analgesia​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Pacira Pharmaceuticals Inc:\n* PACIRA PHARMACEUTICALS STATEMENT ON FDA ADVISORY COMMITTEE FOR EXPAREL® FOR USE AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA\n* PACIRA PHARMACEUTICALS INC - ‍PRESCRIPTION DRUG USER FEE ACT (PDUFA) DATE FOR COMPLETION OF REVIEW IS APRIL 6, 2018​\n* PACIRA PHARMACEUTICALS INC - ‍FOUR COMMITTEE MEMBERS VOTED TO RECOMMEND FDA APPROVAL OF EXPAREL SNDA​\n* PACIRA PHARMACEUTICALS INC -FDA ‍DID NOT REACH A UNANIMOUS DECISION ON EFFICACY AND SAFETY OF USE OF EXPAREL​\n* PACIRA PHARMACEUTICALS INC - ‍SIX COMMITTEE MEMBERS BELIEVED THAT MORE RESEARCH IS NEEDED TO FURTHER SUPPORT PROPOSED NEW INDICATION FOR EXPAREL SNDA​\n* PACIRA PHARMACEUTICALS INC -FDA ‍COMMITTEE‘S FEEDBACK WILL BE CONSIDERED BY FDA IN ITS REVIEW OF COMPANY‘S SNDA SEEKING EXPANSION OF EXPAREL LABEL​\n* PACIRA - FDA ‍COMMITTEE ‍DID NOT REACH A UNANIMOUS DECISION ON EFFICACY, SAFETY OF USE OF EXPAREL AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T04:43:00.000+02:00",
    "crawled": "2018-02-16T16:47:31.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "pacira",
        "pharmaceutical",
        "inc",
        "pacira",
        "pharmaceutical",
        "statement",
        "fda",
        "advisory",
        "committee",
        "use",
        "nerve",
        "block",
        "produce",
        "regional",
        "analgesia",
        "pacira",
        "pharmaceutical",
        "inc",
        "drug",
        "user",
        "fee",
        "act",
        "pdufa",
        "date",
        "completion",
        "review",
        "april",
        "pacira",
        "pharmaceutical",
        "inc",
        "committee",
        "member",
        "voted",
        "recommend",
        "fda",
        "approval",
        "exparel",
        "pacira",
        "pharmaceutical",
        "inc",
        "reach",
        "unanimous",
        "decision",
        "efficacy",
        "safety",
        "use",
        "pacira",
        "pharmaceutical",
        "inc",
        "committee",
        "member",
        "believed",
        "research",
        "needed",
        "support",
        "proposed",
        "new",
        "indication",
        "exparel",
        "pacira",
        "pharmaceutical",
        "inc",
        "feedback",
        "considered",
        "fda",
        "review",
        "company",
        "snda",
        "seeking",
        "expansion",
        "exparel",
        "pacira",
        "fda",
        "reach",
        "unanimous",
        "decision",
        "efficacy",
        "safety",
        "use",
        "exparel",
        "nerve",
        "block",
        "produce",
        "regional",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}